200 related articles for article (PubMed ID: 32210323)
21. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.
Seiffge DJ; Werring DJ; Paciaroni M; Dawson J; Warach S; Milling TJ; Engelter ST; Fischer U; Norrving B
Lancet Neurol; 2019 Jan; 18(1):117-126. PubMed ID: 30415934
[TBL] [Abstract][Full Text] [Related]
22. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke.
Jucevičiūtė N; Mikužis P; Balnytė R
BMC Neurol; 2019 Jun; 19(1):127. PubMed ID: 31195995
[TBL] [Abstract][Full Text] [Related]
23. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
24. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
[TBL] [Abstract][Full Text] [Related]
25. Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin.
Aronow WS; Ahn C; Kronzon I; Gutstein H
J Am Geriatr Soc; 1999 Mar; 47(3):366-8. PubMed ID: 10078902
[TBL] [Abstract][Full Text] [Related]
26. Non-vitamin K antagonist oral anticoagulants versus warfarin in AF patients ≥ 85 years.
Tsai CT; Liao JN; Chen SJ; Jiang YR; Chen TJ; Chao TF
Eur J Clin Invest; 2021 Jun; 51(6):e13488. PubMed ID: 33420738
[TBL] [Abstract][Full Text] [Related]
27. The Role of Double and Triple Therapy with Direct Oral Anticoagulants in Coronary Artery Disease, Peripheral Artery Disease, and Stroke.
Romero N; Lupi K; Carter D; Malloy R
Clin Ther; 2018 Nov; 40(11):1907-1917.e3. PubMed ID: 30458931
[TBL] [Abstract][Full Text] [Related]
28. Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience.
Fahed E; Ghauche J; Rahme R; Okais N; Samaha E; Nohra G; Rizk T; Maarrawi J; Menassa-Moussa L; Moussa R
World Neurosurg; 2016 Nov; 95():143-147. PubMed ID: 27521729
[TBL] [Abstract][Full Text] [Related]
29. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic treatments in patients with acute ischemic stroke and non-valvular atrial fibrillation before introduction of non-vitamin K antagonist oral anticoagulants into practice in Korea.
Bae HJ; Heo JH; Jung KH; Lee YS; Hong KS; Seo WK; Koo J; Cha JK; Lee MJ; Seo BJ; Kim YJ; Kang S; Seok J; Lee J; Chung CS
PLoS One; 2018; 13(11):e0202803. PubMed ID: 30388109
[TBL] [Abstract][Full Text] [Related]
31. Thromboembolic and haemorrhagic events in patients with atrial fibrillation: a prospective cohort study in UK primary and secondary care.
Robson J; Mathur R; Priebe M; Ahmed Z; Ayerbe L
Br J Gen Pract; 2019 Jun; 69(683):e407-e412. PubMed ID: 31015222
[TBL] [Abstract][Full Text] [Related]
32. Risk of Bleeding Following Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Acute Ischemic Stroke Treated With Alteplase.
Tsai TY; Liu YC; Huang WT; Tu YK; Qiu SQ; Noor S; Huang YC; Chou EH; Lai EC; Huang HK
JAMA Intern Med; 2024 Jan; 184(1):37-45. PubMed ID: 37983035
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.
Suh SY; Kang WC; Oh PC; Choi H; Moon CI; Lee K; Han SH; Ahn T; Choi IS; Shin EK
Heart Vessels; 2014 Sep; 29(5):578-83. PubMed ID: 23974943
[TBL] [Abstract][Full Text] [Related]
34. To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
Appelros P; Farahmand B; Terént A; Åsberg S
Stroke; 2017 Jun; 48(6):1617-1623. PubMed ID: 28487335
[TBL] [Abstract][Full Text] [Related]
35. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
Roskell NS; Lip GY; Noack H; Clemens A; Plumb JM
Thromb Haemost; 2010 Dec; 104(6):1106-15. PubMed ID: 20967400
[TBL] [Abstract][Full Text] [Related]
36. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM
Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289
[TBL] [Abstract][Full Text] [Related]
38. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
39. Ischaemic stroke in patients treated with oral anticoagulants.
Cano LM; Cardona P; Quesada H; Lara B; Rubio F
Neurologia; 2016; 31(6):395-400. PubMed ID: 25529172
[TBL] [Abstract][Full Text] [Related]
40. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
Kumar S; de Lusignan S; McGovern A; Correa A; Hriskova M; Gatenby P; Jones S; Goldsmith D; Camm AJ
BMJ; 2018 Feb; 360():k342. PubMed ID: 29444881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
